dalteparin has been researched along with Osteomalacia in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Osteomalacia: Disorder caused by an interruption of the mineralization of organic bone matrix leading to bone softening, bone pain, and weakness. It is the adult form of rickets resulting from disruption of VITAMIN D; PHOSPHORUS; or CALCIUM homeostasis.
Excerpt | Relevance | Reference |
---|---|---|
"Calcifying panniculitis is a rare form of calcinosis cutis belonging to the spectrum of calciphylaxis that has almost invariably been described in patients with severe renal disturbances." | 2.43 | Calcifying panniculitis following subcutaneous injections of nadroparin-calcium in a patient with osteomalacia. ( Borradori, L; Campanelli, A; Kaya, G; Masouyé, I, 2005) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Campanelli, A | 1 |
Kaya, G | 1 |
Masouyé, I | 1 |
Borradori, L | 1 |
1 review available for dalteparin and Osteomalacia
Article | Year |
---|---|
Calcifying panniculitis following subcutaneous injections of nadroparin-calcium in a patient with osteomalacia.
Topics: Anticoagulants; Calciphylaxis; Depression; Female; Humans; Injections, Subcutaneous; Middle Aged; Na | 2005 |